Skip to content

Immunodeficiency 93 And Hypertrophic Cardiomyopathy C5676899

Published: July 22, 2026Updated: August 25, 2026

An extremely rare genetic condition affecting both the immune system and heart muscle. Patients may experience recurrent infections alongside heart thickening, requiring multidisciplinary care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Recurrent infections

(immunologic)

Exercise intolerance

(immunologic)

Palpitations

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunoglobulin replacement therapy

IVIG therapy addresses the immunodeficiency component by providing necessary antibodies while reducing infection frequency and severity.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Cardiac monitoring for hypertrophic cardiomyopathy

Regular echocardiograms, ECGs, and cardiology consultations to monitor cardiac structure and function in patients with HCM features.

monitoring

Additional treatment options

Cardiac medication management

Pharmacological management of HCM symptoms using beta-blockers or calcium channel blockers as appropriate to reduce cardiac workload and improve diastolic function.

medication

Surgical intervention for cardiac complications

Surgical procedures such as septal myectomy or device implantation for severe HCM refractory to medical management.

surgical

Cardiac rehabilitation and physical activity program

Supervised exercise program designed to maintain cardiovascular fitness while respecting cardiac limitations and preventing overexertion.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Immunodeficiency 93 And Hypertrophic Cardiomyopathy C5676899?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Immunodeficiency 93 And Hypertrophic Cardiomyopathy C5676899. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy